Propranolol induced hypoglycemia

Amir Horev, Alon Haim, Alex Zvulunov

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Since 2008, propranolol has become the first line therapy for infantile hemangiomas. Due to the fact that Infantile hemangiomas are the most common vascular tumors of infancy, the use of systemic propranolol has been dramatically increased in the last few years. The reported adverse effects of propranolol in the treatment of Infantile hemangiomas included symptomatic hypoglycemia. In this review we will summarize those reports and will offer guidelines for prevention of hypoglycemia secondary to propranolol therapy.

Original languageEnglish
Pages (from-to)308-310
Number of pages3
JournalPediatric Endocrinology Reviews
Issue number3
StatePublished - 1 Mar 2015


  • Hypoglycemia
  • Infantile hemangioma
  • Propranolol


Dive into the research topics of 'Propranolol induced hypoglycemia'. Together they form a unique fingerprint.

Cite this